Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-039303
Filing Date
2021-10-05
Accepted
2021-10-05 19:11:52
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4325
  Complete submission text file 0000899243-21-039303.txt   5916
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Ros Matthew (Reporting) CIK: 0001673802 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 211308262